<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39274228</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence and Risk Factors of Headache Associated with COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5013</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13175013</ELocationID><Abstract><AbstractText><b>Background:</b> Headache is a prevalent and disabling non-respiratory symptom of COVID-19, posing a persistent challenge in post-COVID syndrome. This study aimed to determine the prevalence, phenotypes, risk factors and biomarkers associated with COVID-related headaches. <b>Methods:</b> A retrospective analysis of 634 hospitalized COVID-19 patients was conducted, with 295 participants being followed up 12-15 months post-discharge via telephone call. Initial laboratory workups, including complete blood count and various biochemical parameters, were compared between headache and non-headache groups. <b>Results:</b> One-third of hospitalized patients experienced headaches, predominantly younger individuals (<i>p</i> &lt; 0.001) and women (<i>p</i> = 0.002). Non-dominant headaches were characterized as dull (56.9%) and holocranial (26.5%), while dominant headaches were unilateral (31.3%) with photophobia (34.3%) and nausea (56.3%). Persistent headaches were unilateral (40%) and pulsating (38%) with phonophobia (74%). Decreased CD4 T cells independently predicted COVID-associated headaches, with elevated IL-6 levels noted in the dominant-headache group (<i>p</i> = 0.040). Remarkably, 50% of patients reported persistent headaches 12-15 months post-infection. Dexamethasone administration significantly reduced the likelihood of long-COVID headaches (52% vs. 73%, <i>p</i> = 0.029). <b>Conclusions:</b> Headache was present in one-third of patients with heterogenous phenotypes: tension headache in the non-dominant group, and migraine in the dominant and persistent headache groups. Persistent headache remains a challenge, with dexamethasone showing potential in reducing its incidence, emphasizing the need for tailored approaches in managing long-COVID headaches.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duran&#xed;kov&#xe1;</LastName><ForeName>O&#x13e;ga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, 813 72 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horv&#xe1;thov&#xe1;</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, 813 72 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabaka</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9337-8843</Identifier><AffiliationInfo><Affiliation>Department of Infectology and Geographical Medicine, Faculty of Medicine, Comenius University Bratislava, 813 72 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min&#xe1;r</LastName><ForeName>Michal</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0812-2366</Identifier><AffiliationInfo><Affiliation>2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, 813 72 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolekov&#xe1;</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2076-1096</Identifier><AffiliationInfo><Affiliation>2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, 813 72 Bratislava, Slovakia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Psychology, Institute of Clinical Psychology, Pan-European University, 821 02 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straka</LastName><ForeName>Igor</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-1134-7029</Identifier><AffiliationInfo><Affiliation>2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, 813 72 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valkovi&#x10d;</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7837-8781</Identifier><AffiliationInfo><Affiliation>2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, 813 72 Bratislava, Slovakia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, 813 71 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>VEGA 2/0076/22</GrantID><Agency>Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">headache</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39274228</ArticleId><ArticleId IdType="pmc">PMC11396359</ArticleId><ArticleId IdType="doi">10.3390/jcm13175013</ArticleId><ArticleId IdType="pii">jcm13175013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caronna E., Pozo-Rosich P. Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research. Curr. Pain. Headache Rep. 2021;25:73. doi: 10.1007/s11916-021-00987-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-021-00987-8</ArticleId><ArticleId IdType="pmc">PMC8583579</ArticleId><ArticleId IdType="pubmed">34766205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B.M., De Vrij F.M.S., Kushner S.A., Harschnitz O., Van Riel D. The Neuroinvasiveness, Neurotropism, and Neurovirulence of SARS-CoV-2. Trends Neurosci. 2022;45:358&#x2013;368. doi: 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo J., Garc&#xed;a-Azor&#xed;n D., Sierra-Menc&#xed;a &#xc1;., Tamayo-Velasco &#xc1;., Mart&#xed;nez-Paz P., Tamayo E., Guerrero A.L., Gonzalo-Benito H. Cytokine and Interleukin Profile in Patients with Headache and COVID-19: A Pilot, CASE-Control, Study on 104 Patients. J. Headache Pain. 2021;22:51. doi: 10.1186/s10194-021-01268-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01268-w</ArticleId><ArticleId IdType="pmc">PMC8177251</ArticleId><ArticleId IdType="pubmed">34088273</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Martinez A., Fanjul V., Ramos C., Serrano Ballesteros J., Bustamante M., Villa Mart&#xed; A., &#xc1;lvarez C., Garc&#xed;a Del &#xc1;lamo Y., Vivancos J., Gago-Veiga A.B. Headache during SARS-CoV-2 Infection as an Early Symptom Associated with a More Benign Course of Disease: A Case&#x2013;Control Study. Eur. J. Neurol. 2021;28:3426&#x2013;3436. doi: 10.1111/ene.14718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14718</ArticleId><ArticleId IdType="pubmed">33417287</ArticleId></ArticleIdList></Reference><Reference><Citation>Guanche Garcell H., Guti&#xe9;rrez Garc&#xed;a F., Ramirez Nodal M., Ruiz Lozano A., P&#xe9;rez D&#xed;az C.R., Gonz&#xe1;lez Vald&#xe9;s A., Gonzalez Alvarez L. Clinical Relevance of Zika Symptoms in the Context of a Zika Dengue Epidemic. J. Infect. Public Health. 2020;13:173&#x2013;176. doi: 10.1016/j.jiph.2019.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2019.07.006</ArticleId><ArticleId IdType="pubmed">31399372</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio Rocha-Filho P.A., Torres R.C.S., Ramos Montarroyos U. HIV and Headache: A Cross-Sectional Study. Headache. 2017;57:1545&#x2013;1550. doi: 10.1111/head.13183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13183</ArticleId><ArticleId IdType="pubmed">28905376</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Yang X., Mei X., Zhou Y., Tang Z., Li G., Zhong J., Yu M., Huang M., Su X., et al. SARS-CoV-2-Specific CD4+ T Cells Are Associated with Long-Term Persistence of Neutralizing Antibodies. Sig Transduct. Target. Ther. 2022;7:132. doi: 10.1038/s41392-022-00978-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00978-0</ArticleId><ArticleId IdType="pmc">PMC9034077</ArticleId><ArticleId IdType="pubmed">35461307</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo J., Garc&#xed;a-Azor&#xed;n D., Planchuelo-G&#xf3;mez &#xc1;., Mart&#xed;nez-P&#xed;as E., Talavera B., Hern&#xe1;ndez-P&#xe9;rez I., Valle-Pe&#xf1;acoba G., Sim&#xf3;n-Campo P., De Lera M., Chavarr&#xed;a-Miranda A., et al. Factors Associated with the Presence of Headache in Hospitalized COVID-19 Patients and Impact on Prognosis: A Retrospective Cohort Study. J. Headache Pain. 2020;21:94. doi: 10.1186/s10194-020-01165-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-020-01165-8</ArticleId><ArticleId IdType="pmc">PMC7388434</ArticleId><ArticleId IdType="pubmed">32727345</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallardo V.J., Shapiro R.E., Caronna E., Pozo-Rosich P. The Relationship of Headache as a Symptom to COVID-19 Survival: A Systematic Review and Meta-analysis of Survival of 43,169 Inpatients with COVID-19. Headache. 2022;62:1019&#x2013;1028. doi: 10.1111/head.14376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14376</ArticleId><ArticleId IdType="pmc">PMC9539239</ArticleId><ArticleId IdType="pubmed">36053077</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X., Ouyang J., Isnard S., Lin J., Fombuena B., Zhu B., Routy J.-P. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System. Front. Immunol. 2020;11:596631. doi: 10.3389/fimmu.2020.596631.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.596631</ArticleId><ArticleId IdType="pmc">PMC7770166</ArticleId><ArticleId IdType="pubmed">33384690</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakshit S., Parthiban Ch Mudhavan R., Adiga V., Eveline J.S., Kumar N.C.H., Ahmed A., Shivalingaiah S., Shashikumar N., Mamatha V., Rose Johnson A., et al. Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN&#xae; induced immunity in COVID-19 exposed Indians. Npj Vaccines. 2023;8:134. doi: 10.1038/s41541-023-00731-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-023-00731-w</ArticleId><ArticleId IdType="pmc">PMC10502007</ArticleId><ArticleId IdType="pubmed">37709772</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.-M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Planchuelo-G&#xf3;mez &#xc1;., Trigo J., de Luis-Garc&#xed;a R., Guerrero &#xc1;.L., Porta-Etessam J., Garc&#xed;a-Azor&#xed;n D. Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis. Front. Neurol. 2020;11:583870. doi: 10.3389/fneur.2020.583870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.583870</ArticleId><ArticleId IdType="pmc">PMC7773780</ArticleId><ArticleId IdType="pubmed">33391152</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo L&#xf3;pez J., Garc&#xed;a-Azor&#xed;n D., Planchuelo-G&#xf3;mez &#xc1;., Garc&#xed;a-Iglesias C., Due&#xf1;as-Guti&#xe9;rrez C., Guerrero &#xc1;.L. Phenotypic Characterization of Acute Headache Attributed to SARS-CoV-2: An ICHD-3 Validation Study on 106 Hospitalized Patients. Cephalalgia. 2020;40:1432&#x2013;1442. doi: 10.1177/0333102420965146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965146</ArticleId><ArticleId IdType="pmc">PMC7645601</ArticleId><ArticleId IdType="pubmed">33146037</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiawati E., Kusuma H.I., Fahriani M., Harapan H., Syahrul S., Musadir N. Headache in Post-COVID-19 Patients: Its Characteristics and Relationship with the Quality of Life. Medicina. 2022;58:1500. doi: 10.3390/medicina58101500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101500</ArticleId><ArticleId IdType="pmc">PMC9609032</ArticleId><ArticleId IdType="pubmed">36295660</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Van Den Hoek T.C., Bolay H., Garcia-Azorin D., Gago-Veiga A.B., Valeriani M., Takizawa T., Messlinger K., Shapiro R.E., Goadsby P.J., et al. Headache Attributed to SARS-CoV-2 Infection, Vaccination and the Impact on Primary Headache Disorders of the COVID-19 Pandemic: A Comprehensive Review. Cephalalgia. 2023;43:033310242211313. doi: 10.1177/03331024221131337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024221131337</ArticleId><ArticleId IdType="pubmed">36606562</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D., Sierra &#xc1;., Trigo J., Alberdi A., Blanco M., Calcerrada I., Cornejo A., Cubero M., Gil A., Garc&#xed;a-Iglesias C., et al. Frequency and Phenotype of Headache in COVID-19: A Study of 2194 Patients. Sci. Rep. 2021;11:14674. doi: 10.1038/s41598-021-94220-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94220-6</ArticleId><ArticleId IdType="pmc">PMC8290038</ArticleId><ArticleId IdType="pubmed">34282206</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues A.N., Dias A.R.N., Paranhos A.C.M., Silva C.C., Bastos T.D.R., Brito B.B.D., Da Silva N.M., De Sousa E.D.J.S., Quaresma J.A.S., Falc&#xe3;o L.F.M. Headache in Long COVID as Disabling Condition: A Clinical Approach. Front. Neurol. 2023;14:1149294. doi: 10.3389/fneur.2023.1149294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1149294</ArticleId><ArticleId IdType="pmc">PMC10076861</ArticleId><ArticleId IdType="pubmed">37034080</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita K., Otsuka Y., Sunada N., Honda H., Tokumasu K., Nakano Y., Sakurada Y., Obika M., Hagiya H., Otsuka F. Manifestation of Headache Affecting Quality of Life in Long COVID Patients. JCM. 2023;12:3533. doi: 10.3390/jcm12103533.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12103533</ArticleId><ArticleId IdType="pmc">PMC10219375</ArticleId><ArticleId IdType="pubmed">37240639</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N., Nakano Y., Otsuka Y., Tokumasu K., Honda H., Sakurada Y., Matsuda Y., Hasegawa T., Omura D., Ochi K., et al. Characteristics of Sleep Disturbance in Patients with Long COVID: A Retrospective Observational Study in Japan. JCM. 2022;11:7332. doi: 10.3390/jcm11247332.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247332</ArticleId><ArticleId IdType="pmc">PMC9783729</ArticleId><ArticleId IdType="pubmed">36555948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y., Otsuka Y., Honda H., Sunada N., Tokumasu K., Sakurada Y., Matsuda Y., Hasegawa T., Ochi K., Hagiya H., et al. Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan. Medicina. 2022;58:1393. doi: 10.3390/medicina58101393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101393</ArticleId><ArticleId IdType="pmc">PMC9611667</ArticleId><ArticleId IdType="pubmed">36295554</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi &#xc1;., Ybarra-Falc&#xf3;n C., Iglesias-Echeverr&#xed;a C., Garc&#xed;a-G&#xf3;mez M., Marcos-Mangas M., Valle-Pe&#xf1;acoba G., Carrasco-Moraleja M., Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Guerrero &#xc1;.L., Garc&#xed;a-Azor&#xed;n D. Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache. Int. J. Environ. Res. Public Health. 2022;19:3961. doi: 10.3390/ijerph19073961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19073961</ArticleId><ArticleId IdType="pmc">PMC8997887</ArticleId><ArticleId IdType="pubmed">35409644</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-Acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.-Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 Infection and Persistence in the Human Body and Brain at Autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Planchuelo-G&#xf3;mez &#xc1;., Garcia-Azor&#xed;n D., Aja-Fern&#xe1;ndes S., Rodr&#xed;guez M., Guerrero A.L., Moro R., De Luis-Garcia R. White Matter Microstructural Alterations in Patients with Persistent Headache after COVID-19 Infection: An Exploratory Study. International Headache Society &amp; European Headache Federation; Proceedings of the International Headache Congress; Berlin, Germany. 8&#x2013;12 September 2021;  [(accessed on 8 September 2021)].  Available online:  https://journals.sagepub.com/doi/pdf/10.1177/03331024211034005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211034005</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundmann A., Wu C., Hardwick M., Baillie J.K., Openshaw P.J.M., Semple M.G., B&#xf6;hning D., Pett S., Michael B.D., Thomas R.H., et al. Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir. Ann. Neurol. 2023;93:88&#x2013;102. doi: 10.1002/ana.26536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26536</ArticleId><ArticleId IdType="pmc">PMC9874556</ArticleId><ArticleId IdType="pubmed">36261315</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hashel J.Y., Ismail I.I. Impact of Coronavirus Disease 2019 (COVID-19) Pandemic on Patients with Migraine: A Web-Based Survey Study. J. Headache Pain. 2020;21:115. doi: 10.1186/s10194-020-01183-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-020-01183-6</ArticleId><ArticleId IdType="pmc">PMC7513457</ArticleId><ArticleId IdType="pubmed">32972360</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelayo-Gonz&#xe1;lez H.J., Reyes-Meza V., M&#xe9;ndez-Balbuena I., M&#xe9;ndez-D&#xed;az O., Trenado C., Ruge D., Garc&#xed;a-Aguilar G., L&#xf3;pez-Cort&#xe9;s V.A. Quantitative Electroencephalographic Analysis in Women with Migraine during the Luteal Phase. Appl. Sci. 2023;13:7443. doi: 10.3390/app13137443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app13137443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>